Insider · CIK 0002080625
Kyle Kline
Files at GMED (GLOBUS MEDICAL INC). First filing Dec 3, 2025, latest Jan 12, 2026.
In brief
Kyle Kline files SEC Form 4 as CFO at GMED (GLOBUS MEDICAL INC). Since Dec 3, 2025, Kyle Kline has reported 0 open-market buys worth $0 and 2 open-market sells worth $2.0M, the latest filed on Jan 12, 2026.
A track record needs three past buys with six months of prices behind them; Kyle Kline has 0, so none is measured yet.
The newest scored trade: sold $363k of GMED on Jan 8, 2026, filed Jan 12, 2026, scored 30 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 2 sells worth $2.0M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
GMED: GLOBUS MEDICAL INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | GLOBUS MEDICAL INC | $363k 3,594 shares | -100% | +82% from low0% from high | |
| 47Moderate | GLOBUS MEDICAL INC | $1.7M 18,542 shares | -100% | +73% from low-4% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jan 8, 2026 | GMED GLOBUS MEDICAL INC | 3,594 0.00% of outstanding | $363k | Jan 8, 2026 | $1.7M |
| Dec 1, 2025 | GMED GLOBUS MEDICAL INC | 18,542 0.01% of outstanding | $1.7M | Dec 1, 2025 | none |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 21, 2026 | GMED GLOBUS MEDICAL INC | AGrant or award Stock Option (Right to Buy Class A Common Stock)derivative | +30,000 | $0.00 | $0 | 30,000 | Jan 23, 2026 |
| Dec 1, 2025 | GMED GLOBUS MEDICAL INC | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative | -4,896 | $0.00 | $0 | 104 | Jan 13, 2026 |
| Jan 8, 2026 | GMED GLOBUS MEDICAL INC | MOption exercise Class A Common Stock10b5-1 | +3,594 | $51.87 | $186k | 3,594 | Jan 12, 2026 |
| Jan 8, 2026 | GMED GLOBUS MEDICAL INC | SOpen-market sale Class A Common Stock10b5-1 | -3,594 | $101.10 | $363k | 0 | Jan 12, 2026 |
| Jan 8, 2026 | GMED GLOBUS MEDICAL INC | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative10b5-1 | -3,594 | $0.00 | $0 | 3,906 | Jan 12, 2026 |
| Dec 1, 2025 | GMED GLOBUS MEDICAL INC | MOption exercise Class A Common Stock10b5-1 | +3,646 | $53.14 | $194k | 3,646 | Dec 3, 2025 |
| Dec 1, 2025 | GMED GLOBUS MEDICAL INC | MOption exercise Class A Common Stock10b5-1 | +5,000 | $56.43 | $282k | 8,646 | Dec 3, 2025 |
| Dec 1, 2025 | GMED GLOBUS MEDICAL INC | MOption exercise Class A Common Stock10b5-1 | +5,000 | $64.44 | $322k | 13,646 | Dec 3, 2025 |
| Dec 1, 2025 | GMED GLOBUS MEDICAL INC | MOption exercise Class A Common Stock10b5-1 | +4,896 | $63.68 | $312k | 18,542 | Dec 3, 2025 |
| Dec 1, 2025 | GMED GLOBUS MEDICAL INC | SOpen-market sale Class A Common Stock10b5-1 | -18,542 | $90.00 | $1.7M | 0 | Dec 3, 2025 |
| Dec 1, 2025 | GMED GLOBUS MEDICAL INC | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative10b5-1 | -3,646 | $0.00 | $0 | 1,354 | Dec 3, 2025 |
| Dec 1, 2025 | GMED GLOBUS MEDICAL INC | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative10b5-1 | -5,000 | $0.00 | $0 | 10,000 | Dec 3, 2025 |
| Dec 1, 2025 | GMED GLOBUS MEDICAL INC | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative10b5-1 | -5,000 | $0.00 | $0 | 0 | Dec 3, 2025 |
| Dec 1, 2025 | GMED GLOBUS MEDICAL INC | MOption exercise Stock Option (Right to Buy Class A Common Stock)derivative10b5-1 | -5,000 | $0.00 | $0 | 0 | Dec 3, 2025 |
| Jul 18, 2025 | GMED GLOBUS MEDICAL INC | AGrant or award Stock Option (Right to Buy Class A Common Stock)derivative | +20,909 | $0.00 | $0 | 20,909 | Aug 27, 2025 |
Questions about Kyle Kline
Answered from the filings on this page, as of the latest one.
Is Kyle Kline buying or selling?
In the last 12 months Kyle Kline reported 0 open-market buys worth $0 and 2 open-market sells worth $2.0M on SEC Form 4; the latest was sold $363k of GMED on Jan 8, 2026. Grants, option exercises and tax withholding are not counted.
How did Kyle Kline's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kyle Kline has 0.
Where does Kyle Kline file Form 4?
Kyle Kline has filed Form 4 at GMED (GLOBUS MEDICAL INC) as Senior Vice President, CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.